Home Business Starbucks (SBUX) Q1 2021 earnings top estimates

Starbucks (SBUX) Q1 2021 earnings top estimates

Kevin Johnson, CEO, Starbucks

Scott Mlyn | CNBC

Starbucks on Tuesday reported that its U.S. same-store sales fell 5% during its fiscal first quarter after a surge of new Covid-19 cases led to harsher dining restrictions.

Here’s what the company reported compared with what Wall Street was expecting, based on a survey of analysts by Refinitiv:

  • Earnings per share: 61 cents, adjusted, vs. 55 cents expected
  • Revenue: $6.75 billion vs. $6.93 billion expected

Excluding items, the coffee giant earned 61 cents per share, topping the 55 cents per share expected by analysts surveyed by Refinitiv.

Net sales dropped 5% to $6.7 billion, falling short of expectations of $6.9 billion. Worldwide, the company’s same-store sales fell 5%. The chain saw 19% fewer transactions during the quarter, but the average ticket jumped 17%.

In the U.S., same-store sales fell by 5%. The company’s recovery in its home market was hampered by another surge of new Covid-19 cases as the temperatures grew colder. The number of Starbucks Rewards members who have been active in the last 90 days rose 15% to 21.8 million people.

In China, Starbucks’ second-largest market, same-store sales turned positive for the first time since the health crisis started. Its same-store sales rose 5%, although transactions still declined compared with the same time a year ago.

The company opened 278 net new cafes during the quarter and now has a footprint nearing 33,000 locations.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Clubhouse Android App Could Be Released as Soon as May 2021

Clubhouse's Android app is under development and recent tweets show that it may be released as early as May 2021. Currently, the...

Daily U.S. data on April 14

Johnson & Johnson COVID-19 vial and box seen at a vaccination site. Doses of the Johnson & Johnson vaccine are being administered throughout the...

Recent Comments